Natco Pharma Ltd

Encumbrance on promoter shares

• Target company: Natco Pharma Limited (NATCOPHARM).
• Encumbrance type: pledge on 8,50,000 Natco Pharma shares.
• Promoter: V. C. Nannapaneni.
• Shares encumbered: 8,50,000 (0.47% of total capital).
• Entity in favour: Financial Securities Limited.
• Date of creation: 09-10-2026.
• Promoter total holding: 28,045,905 shares.
• Diluted share capital: 15.66%.
• End use of funds: not disclosed.

AGM details

• Date and time: 30 September 2026, 11:00 IST, held via Video Conferencing/OA VM.
• Cut-off date for shareholders: 25 September 2026; total shareholders 4,22,879.

Resolutions & outcomes

• Resolution 1: Ordinary – Adoption of Audited Financial Statements for FY2025-26; Passed (99.78%).
• Resolution 2: Ordinary – Final dividend of Rs 5 per share; Approved (99.99%).
• Resolution 3: Ordinary – Re-appointment of Sri P.S.R. K. Prasad; Passed (99.43%).
• Resolution 4: Ordinary – Ratification of remuneration of Cost Auditors; Passed (99.99%).
• Resolution 5: Special – Placement of securities up to Rs 2,000 crore; Passed (98.94%).

Dividend

• Final dividend of Rs 5 per equity share approved.

Directors & auditors

• Director re-appointment: Sri P.S.R. K. Prasad re-appointed; liable to retire by rotation.
• Cost Auditor remuneration ratified.

Material related party transactions

• No material related party transactions approved.

Other material approvals

• Fund-raising approval: up to Rs 2,000 crore via preferential issue or other method.

Natco Pharma Limited: Trading Window closed from October 1, 2026 until 48 hours after the declaration of the Unaudited Financial Results for the quarter ending September 30, 2026

Natco Pharma Limited: Trading Window closed from October 1, 2026 to 48 hours after declaration of unaudited financial results for the quarter ending September 30, 2026

AGM Details

• Date and time: 30 September 2026 at 11:00 IST.
• Mode: Video Conference / Other Audio-Visual Means (OA VM).
• Shareholder cut-off date: 25 September 2026.

Key Resolutions

• Resolution 1 (Ordinary): Adoption of Audited Financial Statements for FY2025-26; passed with 99.78% in favour.
• Resolution 2 (Ordinary): Final dividend of Rs 5 per share; passed with 99.99% in favour.
• Resolution 3 (Ordinary): Re-appointment of Sri P.S.R. K. Prasad as director liable to retirement by rotation; passed 99.43%.
• Resolution 4 (Ordinary): Ratification of remuneration of Cost Auditors; passed 99.99%.
• Resolution 5 (Special): Approval for placement/raising of funds up to Rs 2,000 crore via securities; passed 98.94%.

Dividend

• Dividend approved: Rs 5 per equity share for FY2025-26.

Director Changes

• Re-appointment of director under rotation as per Resolution 3.

Auditors

• Remuneration of Cost Auditors ratified; no statutory auditor details disclosed.

Material Related Party Transactions

• No material related party transactions disclosed beyond fundraising-related approvals.

Other Material Approvals

• Approval for securities issuance up to Rs 2,000 crore.

AGM Details

• Date and time: 30 September 2026, 11:00 AM.
• Mode: Video Conference at Natco House, Hyderabad.

Key Resolutions

• Adoption of audited financial statements for FY 2025-26.
• Interim dividends aggregating ₹5.00 per share paid in FY 2025-26.
• Re-appointment of P.S.R.K. Prasad as Director liable to retire by rotation.
• Ratification of remuneration of Cost Auditors.
• Approval to raise funds up to ₹2,000 crore via securities.

Dividend

• Three interim dividends totaling ₹5.00 per share were paid during FY 2025-26.

Voting Status

• Voting results to be announced within two working days; outcome not disclosed in filing.

Director Changes

• Re-appointment of P.S.R.K. Prasad as Director liable to retire by rotation.

Auditors

• Statutory auditors were present; no appointment, re-appointment, or changes disclosed.

AGM Details

• Date and time: 30 September 2026 at 11:00 AM; mode: video conference.
• Venue: Natco House, Hyderabad; quorum present.
• Statutory Auditors' report: unqualified with no adverse observations.

Key Resolutions

• Adoption of audited financial statements for FY 2025-26.
• Confirmation of three interim dividends aggregating ₹5.00 per share.
• Re-appointment of Sri P.S.R.K. Prasad as Director liable to retire by rotation.
• Ratification of remuneration of Cost Auditors.
• Approval to raise funds by issuance of securities up to ₹2,000 crores.

Voting status

• Voting results awaited; combined remote and on-site results to be announced within two working days.

Key outcomes

• The Fund Raising Committee approved the Letter of Offer for the Rights Issue dated September 28, 2026.
• Board approves rights issue of 17,058,082 shares at ₹750; record date 1 Oct 2026; ratio 2:21; ISIN INE987B20018.
• In-principle listing approvals from NSE and BSE received; listing to be on NSE.
• Issue schedule: Open Oct 12, 2026; close Oct 22, 2026; last credit Oct 6; basis of allotment Oct 23.
• Net proceeds estimated at ₹12,590 million after expenses of ₹204 million.
• Use of net proceeds: ₹8,105m pre-pay/repay borrowings; ₹1,100m for R&D; ₹3,385m for inorganic growth/general corporate.
• Outstanding borrowings as of Aug 31, 2026: ₹9,543 million; prepayment cap ₹8,105 million.
• Crisil Ratings Limited appointed Monitoring Agency; proceeds to be held in a separate bank account with quarterly reporting.
• Minimum subscription 90%; if not achieved, refunds within four days; unsubscribed portion may be allotted or disposed.
• Rights entitlements and trading: dematerialised only; ISIN INE987B20018; on-market renunciation Oct 12–16; off-market renunciation allowed; market lot 1.